Molecular diagnostic approaches in detecting rearranged during transfection oncogene mutations in multiple endocrine neoplasia type 2

doi:10.12998/wjcc.v12.i31.6436

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 31

This Article

(0) (0) (0)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2289)

All Articles published online

Item

Count

PDF

120

HTML

1271

Sum=1391

Publishing Process of This Article

Item

Count

Browse

130

Download

634

Sum=764

Nov 6, 2024 (publication date) through May 20, 2026

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Cases. Nov 6, 2024; 12(31): 6436-6440
Published online Nov 6, 2024. doi: 10.12998/wjcc.v12.i31.6436

Molecular diagnostic approaches in detecting rearranged during transfection oncogene mutations in multiple endocrine neoplasia type 2

Sambasivam Gopinath, Velmurugan Ramaiyan

Sambasivam Gopinath, Velmurugan Ramaiyan, Department of Pharmacy, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Chennai 602105, India

Author contributions: Gopinath S designed the overall concept and outline of the manuscript; Velmurugan R contributed to the discussion and design of the manuscript; Gopinath S and Velmurugan R contributed to the writing and editing of the manuscript, and review of the literature; all authors have read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Corresponding author: Velmurugan Ramaiyan, PhD, Professor, Department of Pharmacy, Saveetha College of Pharmacy, Saveetha Institute of Medical and Technical Sciences, Saveetha Nagar, Chennai Bengaluru, NH 48, Chennai 602105, India. ramaiyan.dr@gmail.com

Received: May 29, 2024
Revised: July 26, 2024
Accepted: August 1, 2024
Published online: November 6, 2024
Processing time: 104 Days and 23.4 Hours

Core Tip

Core Tip: In this editorial, we provide a commentary on a case report. The authors aimed to study the rearranged during transfection (RET) gene mutations, clinical characteristics, and treatment strategies in a family with multiple endocrine neoplasia type 2 (MEN2). Although RET gene mutation increases the risk of endocrine tumors and hyperplasia, a lack of proper diagnosis and molecular testing can undermine the management of patients with MEN2. In this editorial article, we focus on the significance of molecular testing in MEN2.